Fuji Pharma Co.,Ltd.【JP:4554】Cash flow
Market cap
¥47.6B
P/E ratio
12.3x
| 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Depreciation & amortization | 1,376 | 1,768 | 1,667 | 1,769 | 1,976 | 1,850 | 1,774 | 1,828 | 2,462 | 2,707 | 3,343 | 3,875 |
| Cash from operations | 2,757 | 589 | 4,509 | 3,238 | 3,773 | 7,035 | 5,770 | 5,993 | -658 | 1,917 | 4,151 | 5,801 |
| Capital expenditures | -1,079 | -1,512 | -2,308 | -1,477 | -1,446 | -1,701 | -2,322 | -3,789 | -5,097 | -3,327 | -2,778 | -1,981 |
| Cash from investing | -1,975 | 999 | -3,319 | -1,534 | -1,073 | -12,024 | -2,616 | -2,345 | -11,271 | -5,240 | -1,658 | -4,219 |
| Payments for dividends | -593 | -675 | -674 | -704 | -794 | -839 | -904 | -807 | -729 | -899 | -972 | -1,036 |
| Repurchases of common stock | - | -1,504 | - | - | -40 | - | - | -9,405 | - | - | - | - |
| Proceeds from issuance of term debt, net | - | - | 2,000 | - | - | 7,000 | 4,000 | 1,000 | 7,300 | - | - | 9,000 |
| Repayments of term debt | -921 | -921 | -921 | -1,921 | -653 | -630 | -3,140 | -1,756 | -2,140 | -2,440 | -4,610 | -7,099 |
| Cash from financing | 1,293 | -4,635 | 78 | -3,042 | -2,001 | 7,265 | 450 | -5,435 | 5,094 | 1,915 | -435 | 954 |
| Free cash flow | ||||||||||||
| FCF margin (%) |